Systematic review with meta-analysis: The diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B

Alimentary Pharmacology and Therapeutics

Volumn 43, Issue 4, 2016, Pages 458-469

  Li, Y ^a   Huang, Y S ^a   Wang, Z Z ^a   Yang, Z R ^a   Sun, F ^a   Zhan, S Y ^a   Liu, X E ^a   Zhuang, H ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC HEPATITIS B; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ELASTOGRAPHY; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BIOPSY; ECHOGRAPHY; FEMALE; HEPATITIS B; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATHOLOGY;

BIOPSY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84954372636     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13488     Document Type: Article

References (46)

1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2014; 60: 392-420.
2. Tatsumi C, Kudo M, Ueshima K, et al,. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography. Intervirology 2008; 51: 27-33.
3. Sandrin L, Fourquet B, Hasquenoph J-M, et al,. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
4. Chan HL, Wong GL, Choi PC, et al,. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepatitis 2009; 16: 36-44.
5. Goyal R, Mallick SR, Mahanta M, et al,. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B. J Gastroenterol Hepatol 2013; 28: 1738-45.
6. Chon YE, Choi EH, Song KJ, et al,. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS ONE 2012; 7: e44930.
7. Steadman R, Myers RP, Leggett L, et al,. A health technology assessment of transient elastography in adult liver disease. Can J Gastroenterol 2013; 27: 149-58.
8. Whiting PF, Rutjes AW, Westwood ME, et al,. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-36.
9. Wu L, Zhang Y, Zeng XT,. The QUADAS-2 Tool for the Quality Assessment of Diagnostic Accuracy Study: an introduction. Hubei Yiyao Xueyuan Xuebao 2013; 3: 201-8.
10. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y,. Chapter 10: analysing and presenting results. In:, Deeks JJ, Bossuyt PM, Gatsonis C, eds. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. Available at: http://srdta.cochrane.org/. Accessed on 26 August 2015.
11. Rutter CM, Gatsonis CA,. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001; 20: 2865-84.
12. Harbord RM, Whiting P,. Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J 2009; 9: 211-29.
13. Dwamena B, Sylvester R, Carlos RC,. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. Statistical software components: s456880 2009;2-25. Available at: http://www.bc.edu/repec/bocode/m/midas.pdf. Accessed on 28 October 2015.
14. Ding H, Wu T, Ma K, et al,. Noninvasive measurement of liver fibrosis by transient elastography and influencing factors in patients with chronic hepatitis B-A single center retrospective study of 466 patients. Huazhong Da Xue Xue Bao(Sci-Med) 2012; 32: 69-74.
15. Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M,. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 2010; 30: 1471-80.
16. Sinakos E, Manolakopoulos S, Papatheodoridis G, et al,. Transient elastography (Fibroscan) in patients with chronic hepatitis B in everyday clinical practice. J Hepatol 2011; 54: S140-S141.
17. Wong GL, Wong VW, Choi PC, et al,. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol 2008; 6: 1027-35.
18. Chen YP, Liang XE, Zhang Q, et al,. Larger biopsies evaluation of transient elastography for detecting advanced fibrosis in patients with compensated chronic hepatitis B. J Gastroenterol Hepatol 2012; 27: 1219-26.
19. Kim Do Y, Kim SU, Ahn SH, et al,. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2009; 54: 1758-63.
20. Kim SU, Ahn SH, Park JY, et al,. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J Clin Gastroenterol 2009; 43: 267-71.
21. Marcellin P, Ziol M, Bedossa P, et al,. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-7.
22. Wang JH, Changchien CS, Hung CH, et al,. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J Gastroenterol 2009; 44: 439-46.
23. Sporea I, Sirli R, Deleanu A, et al,. Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World J Gastroenterol 2010; 16: 4832-7.
24. Chen XB, Zhu X, Chen LY, et al,. Accuracy of Fibroscan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2011; 19: 286-90.
25. Lesmana CR, Salim S, Hasan I, et al,. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting. J Clin Pathol 2011; 64: 916-20.
26. Osakabe K, Ichino N, Nishikawa T, et al,. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol 2011; 46: 1324-34.
27. Zhang X, Lu W, Wang CY,. Diagnostic value of Fibroscan for liver fibrosis in patients with chronic hepatitis B. Tianjin Yi Yao Zazhi 2011; 39: 236-8.
28. Zhu X, Wang LC, Chen EQ, et al,. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci 2011; 56: 2742-9.
29. Cho HJ, Seo YS, Lee KG, et al,. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients. J Gastroenterol Hepatol 2011; 26: 492-500.
30. Stibbe KJ, Verveer C, Francke J, et al,. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroenterol 2011; 46: 962-72.
31. Vigano M, Paggi S, Lampertico P, et al,. Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation. Aliment Pharmacol Ther 2011; 34: 353-62.
32. Cardoso AC, Carvalho-Filho RJ, Stern C, et al,. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 2012; 32: 612-21.
33. Chen YP, Liang XE, Dai L, et al,. Improving transient elastography performance for detecting hepatitis B cirrhosis. Dig Liver Dis 2012; 44: 61-6.
34. Kim BK, Kim SU, Kim HS, et al,. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS ONE 2012; 7: e35825.
35. Kim BK, Kim HS, Park JY, et al,. Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B. PLoS ONE 2012; 7: e41964.
36. Kim SU, Kim JK, Park YN, et al,. Discordance between liver biopsy and FibroScan (R) in assessing liver fibrosis in chronic hepatitis B: risk factors and influence of necroinflammation. PLoS ONE 2012; 7: e32233.
37. Li JZ, Li J, Xiong CM, et al,. Clinical value of Fibroscan stiffness measurement and ultrasonography in diagnosing chronic hepatitis B-related fibrosis. Shangdong Da Xue Xue Bao (Health Sciences) 2012; 50: 115-8.
38. Liu ZQ, Feng JH, Xiao Q, et al,. Application of FibroScan for diagnosis of liver fibrosis in patients with chronic hepatitis B. Zhongguo Quan Ke Yi Xue Zazhi 2012; 15: 4068-70.
39. Zhang J, Li B, Li F, et al,. Accuracy of FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B. Chuan Ran Bing Xin Xi Zazhi 2013; 3: 146-8.
40. Trembling PM, Lampertico P, Parkes J, et al,. Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection. J Viral Hepatitis 2014; 21: 430-8.
41. Wong GL, Chan HL, Choi PC, et al,. Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2014; 39: 197-208.
42. World Health Organization (WHO). Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection, 2015. Available at: http://www.who.int/. Accessed on 26 August 2015.
43. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK,. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-9.
44. Kim SU, Seo YS, Cheong JY, et al,. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther 2010; 32: 498-505.
45. Sebastiani G, Halfon P, Castera L, et al,. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1821-7.
46. Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A,. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointest Liver 2009; 18: 57-60.